Vital Therapies, Inc. (VTL)

[420man]

Talk about a massive loss.....

Item 3. Source and Amount of Funds.

Item 3 of the Prior Filings is amended by adding the following paragraph:
Between September 13, 2018 and September 17, 2018, the Reporting Person sold an aggregate of 11,382,277 shares of Common Stock at a weighted average price of $0.3642. These shares were sold in multiple transactions at prices ranging from $0.24 to $0.598.